A groundbreaking mobile application powered by artificial intelligence is set to transform the way kidney diseases are detected and treated. Developed by the startup Hellokidney.ai, this innovative solution aims to revolutionize kidney care by leveraging digital technology, point-of-care testing, and clinical decision-aid tools.
Under the National Health Mission (NHM), the state government has given the green signal to launch a pilot project in the districts of Uddanam, A Konduru, Krishna, and Guntur. This project, in collaboration with an international agency, seeks to introduce screening for kidney diseases using the Hellokidney.ai app.
Dr. Chinta Ramakrishna, a renowned nephrologist from Guntur, is the mastermind behind Hellokidney.ai. After conducting extensive research in partnership with international institutions and studying hundreds of patient cases for over two years, Dr. Ramakrishna developed this cutting-edge mobile application.
Speaking about the project, Dr. Ramakrishna said, “Hellokidney.ai is a technological innovation that bridges gaps in kidney care and aims to redefine kidney health outcomes. By leveraging digital technology, point-of-care testing, and clinical decision-aid tools, we hope to save lives.”
The Hellokidney.ai app employs a comprehensive range of features, including mobile digital health applications, point-of-care testing for creatinine estimation, estimated GFR (glomerular filtration rate), and urine albumin/creatinine ratio calculation. These features enable risk stratification for guideline-directed treatment with clinical decision-aid tools.
In cases of chronic kidney disease (CKD), the app will facilitate the use of proven and safe drugs to prevent kidney failure. This will empower primary care physicians at Primary Health Centers (PHCs) with virtual nephrology expertise, enabling them to provide standardized kidney care.
Under the pilot project, approximately 2,000 at-risk patients for CKD will undergo screening using the Hellokidney.ai app. Diagnosed patients will be categorized into different stages of CKD and guided towards appropriate standard care.
Frequently Asked Questions (FAQ)
1. What is Hellokidney.ai?
Hellokidney.ai is a mobile application that uses artificial intelligence to revolutionize kidney disease screening and treatment.
2. What are the features of Hellokidney.ai?
Hellokidney.ai employs mobile digital health applications, point-of-care testing, and clinical decision-aid tools for risk stratification, treatment guidance, and standardized care.
3. Can primary care physicians use Hellokidney.ai?
Yes, primary care physicians with virtual nephrology expertise can utilize Hellokidney.ai to provide standardized kidney care at Primary Health Centers (PHCs).
4. How many patients will be screened under the pilot project?
Approximately 2,000 at-risk patients for chronic kidney disease (CKD) will undergo screening using the Hellokidney.ai app.
5. What happens to patients diagnosed with CKD?
Diagnosed patients will be categorized into different stages of CKD and guided towards appropriate standard care.
Sources: timesofindia.indiatimes.com
FAQ (Frequently Asked Questions):
1. What is Hellokidney.ai?
Hellokidney.ai is a mobile application that uses artificial intelligence to revolutionize kidney disease screening and treatment.
2. What are the features of Hellokidney.ai?
Hellokidney.ai employs mobile digital health applications, point-of-care testing, and clinical decision-aid tools for risk stratification, treatment guidance, and standardized care.
3. Can primary care physicians use Hellokidney.ai?
Yes, primary care physicians with virtual nephrology expertise can utilize Hellokidney.ai to provide standardized kidney care at Primary Health Centers (PHCs).
4. How many patients will be screened under the pilot project?
Approximately 2,000 at-risk patients for chronic kidney disease (CKD) will undergo screening using the Hellokidney.ai app.
5. What happens to patients diagnosed with CKD?
Diagnosed patients will be categorized into different stages of CKD and guided towards appropriate standard care.
Sources: timesofindia.indiatimes.com
The source of the article is from the blog meltyfan.es